The Interplay between Candida albicans, Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives

R Gaziano, S Sabbatini, C Monari - Microorganisms, 2023 - mdpi.com
Vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans, is an
infection that affects up to 75% of all reproductive-age women worldwide. Recurrent VVC …

Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments

S Martinelli, G Nannini, F Cianchi, F Staderini, F Coratti… - Microorganisms, 2023 - mdpi.com
Fecal microbiota transplantation (FMT) is a procedure that involves transferring fecal
bacteria from a healthy donor to a patients' intestines to restore gut–immunity homeostasis …

Clinical manifestations of human exposure to fungi

M Oliveira, D Oliveira, C Lisboa, JL Boechat… - Journal of Fungi, 2023 - mdpi.com
Biological particles, along with inorganic gaseous and particulate pollutants, constitute an
ever-present component of the atmosphere and surfaces. Among these particles are fungal …

[HTML][HTML] Probiotics in the Management of Vulvovaginal Candidosis

K Akinosoglou, G Schinas, E Polyzou… - Journal of Clinical …, 2024 - mdpi.com
Vulvovaginal candidosis (VVC) represents a frequent and cumbersome vaginal infection.
Recurrent and/or persistent infections remain common among a significant number of …

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection

Y Wang, Z Liu, T Chen - Heliyon, 2024 - cell.com
Vulvovaginal candidiasis (VVC) is the second most common cause of vaginal infection
globally after bacterial vaginosis (BV) and associated with adverse reproductive and …

Efficacy Comparison of Oral and Intravaginal Lactobacillus plantarum Administration on Secreted Aspartyl Protease-5 (SAP5) Levels in Vulvovaginal Candidiasis

RA Fristiyanti, NS Matin, SD Ratnaningrum… - Trends in …, 2024 - tis.wu.ac.th
Vulvovaginal candidiasis (VVC) is the most common fungal infection in the vaginal mucosa
caused by an overgrowth of Candida albicans. The pathogenesis of C. albicans is …

Uso de probióticos como terapia adjuvante no tratamento da candidíase vulvovaginal durante a menacme

JM Figueiredo, MA da Silva Júnior… - Revista Eletrônica …, 2023 - acervomais.com.br
Objetivo: Analisar a produção científica acerca do uso de probióticos como terapia
adjuvante no tratamento da candidíase vaginal. Métodos: Trata-se de uma revisão …

Effectivity Comparison Between Oral and Intravaginal Administration of Lactobacillus Plantarum on Decreasing Levels of TNF-α And IL-6 in Vulvovaginal Candidiasis

Nurdiana, RA Fristiyanti, NS Matin… - Obstetrics and …, 2023 - journals.co.za
Vulvovaginal candidiasis (VVC) is the most common fungal infection in the vaginal mucosa
and vulva caused by Candida albicans. C. albicans cell walls recognized as PAMPs by PRR …

[PDF][PDF] Kan behandlingen af vulvovaginal candidiasis forbedres ved at supplere den konventionelle azolbehandling med probiotika?

A Schmedes, AS Andersen, S Edelberg - speam.dk
Baggrund En ung kvinde kommer i klinikken og beretter om symptomer på vaginal svamp.
Hun har selv forsøgt at behandle det med håndkøbspræparater i form af vaginalcreme, men …

پاسخ به درمان و ارزیابی حساسیت دارویی نسبت به فلوکونازول در زنان مبتال به ولوواژینیت کاندیدایی.

زهرا واحدپور, محمدجواد آزادچه&, طه باغبانی… - Payavard …, 2022‎ - search.ebscohost.com
حرطم نآ یلصا لماع ناونع هب سنکیبلآ ادیدناک هک دشاب یم ولو و نژاو هیحان یچراق تنوفع
ییادیدناک تینیژاوولو: فده و هنیمز داح دراوم یارب جیار یاه نامرد زا یکی ناونع هب یکاروخ …